Edith P. Mitchell - 15 Jun 2023 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
Director
Signature
/s/ Leiv Lea, as Attorney-in-Fact for Edith P. Mitchell
Issuer symbol
CRVS
Transactions as of
15 Jun 2023
Net transactions value
$0
Form type
4
Filing time
20 Jun 2023, 16:57:29 UTC
Previous filing
15 Aug 2022
Next filing
08 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRVS Stock Option (Right to Buy) Award $0 +15,000 $0.000000 15,000 15 Jun 2023 Common Stock 15,000 $2.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2024 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.